EYA4 | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 14 of 14 results for "EYA4"
i
  1. EYA4 is a non-small cell lung cancer tumor suppressor located in the susceptibility locus on chromosome 6q BioProject

    ID: PRJNA120637

    Keywords: Other

    Access Type: download

  2. EYA4 is a non-small cell lung cancer tumor suppressor located in the susceptibility locus on chromosome 6q ArrayExpress

    ID: E-GEOD-19034

    Description: tumour suppressor genes in lung adenocarcinoma. EYA4, located at 6q23.2 was identified as a frequently lost and hypermethylated gene in the analyzed samples. EYA4 is underexpressed in addition to being ...

  3. EYA4 is a non-small cell lung cancer tumor suppressor located in the susceptibility locus on chromosome 6q OmicsDI

    ID: E-GEOD-19034

    Date Released: 05-02-2014

    Description: tumour suppressor genes in lung adenocarcinoma. EYA4, located at 6q23.2 was identified as a frequently lost and hypermethylated gene in the analyzed samples. EYA4 is underexpressed in addition to being ...

  4. An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer: CGH ArrayExpress

    ID: E-GEOD-21540

    Description: tumour suppressor genes in lung adenocarcinoma. EYA4, located at 6q23.2 was identified as a frequently lost and hypermethylated gene in the analyzed samples. 7 Breast cancer cell lines profiled on the SMRTr array in conjun...

  5. An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer: CGH BioProject

    ID: PRJNA129511

    Keywords: Variation

    Access Type: download

    dataset.description: tumour suppressor genes in lung adenocarcinoma. EYA4, located at 6q23.2 was identified as a frequently lost and hypermethylated gene in the analyzed samples. Overall design: 7 Breast cancer cell lines profiled on the SMRTr...
  6. DNA methylation profiling in the Carolina Breast Cancer Study BioProject

    ID: PRJNA223415

    Keywords: Epigenomics

    Access Type: download

    dataset.description: values for the 167 most variant CpG loci defined 4 clusters differing most distinctly in hormone receptor (HR) status, intrinsic subtype (luminal versus basal-like) and p53 mutation status. Supervised analyses for HR status, subtype, and p53 status identified differentially methylated CpG loci with considerable overlap (n=266). Concensus clustering also defined a hypermethylated luminal-enriched tumor cluster 3; gene ontology analysis of cluster 3 hypermethy...
  7. Epigenomic Analysis of Aberrantly Methylated Genes in Colorectal Cancer ArrayExpress

    ID: E-GEOD-17648

    Description: y studies (ADHFE1, BOLL, SLC6A15, ADAMTS5, TFPI2, EYA4, NPY, TWIST1, LAMA1, GAS7) and 2 CpG sites showing hypomethylaion (MAEL, SFT2D3) in CRC compared to normal mucosa using pyrosequencing. The methylation status measured by pyrosequencing was consistent with the methylation array data. In conclusion, we have shown that methylation profiling based on beadchip arrays is an effective method for screening for aberrantly methylated genes in CRC. In addition, we identified novel methylated genes that are candidate diagnostic or prognostic markers for CRC. We measured the methylation status of the 27,578 CpG sites (Human Methylation27 DNA Analysis BeadChip) in 22 pairs of CRC tissue and adjacent normal mucosa to identify genes that are commonly aberrantly methylated in CRC....

  8. DNA methylation profiling in the Carolina Breast Cancer Study ArrayExpress

    ID: E-GEOD-51557

    Description: values for the 167 most variant CpG loci defined 4 clusters differing most distinctly in hormone receptor (HR) status, intrinsic subtype (luminal versus basal-like) and p53 mutation status. Supervised analyses for HR status, subtype, and p53 status identified differentially methylated CpG loci with considerable overlap (n=266). Concensus clustering also defined a hypermethylated luminal-enriched tumor cluster 3; gene ontology analysis of cluster 3 hypermethy...

  9. An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer: CGH OmicsDI

    ID: E-GEOD-21540

    Date Released: 05-01-2014

    Description: tumour suppressor genes in lung adenocarcinoma. EYA4, located at 6q23.2 was identified as a frequently lost and hypermethylated gene in the analyzed samples. 7 Breast cancer cell lines profiled on the SMRTr array in conjun...

  10. EYA4_CHICK UniProt:Swiss-Prot

    ID: Q9YH98

    Description: Eyes absent homolog 4

  11. EYA4_TAKRU UniProt:Swiss-Prot

    ID: Q9YHA1

    Description: Eyes absent homolog 4

  12. Epigenomic Analysis of Aberrantly Methylated Genes in Colorectal Cancer BioProject

    ID: PRJNA118597

    Keywords: Epigenomics

    Access Type: download

    dataset.description: y studies (ADHFE1, BOLL, SLC6A15, ADAMTS5, TFPI2, EYA4, NPY, TWIST1, LAMA1, GAS7) and 2 CpG sites showing hypomethylaion (MAEL, SFT2D3) in CRC compared to normal mucosa using pyrosequencing. The methylation status measured by pyrosequencing was consistent with the methylation array data. In conclusion, we have shown that methylation profiling based on beadchip arrays is an effective method for screening for aberrantly methylated genes in CRC. In addition, we identified novel methylated genes that are candidate diagnostic or prognostic markers for CRC. Overall design: We measured the methylation status of the 27,578 CpG sites (Human Methylation27 DNA Analysis BeadChip) in 22 pairs of CRC tissue and adjacent normal mucosa to identify genes that are commonly aberrantly methylated in CRC....
  13. DNA methylation profiling in the Carolina Breast Cancer Study OmicsDI

    ID: E-GEOD-51557

    Date Released: 04-10-2015

    Description: values for the 167 most variant CpG loci defined 4 clusters differing most distinctly in hormone receptor (HR) status, intrinsic subtype (luminal versus basal-like) and p53 mutation status. Supervised analyses for HR status, subtype, and p53 status identified differentially methylated CpG loci with considerable overlap (n=266). Concensus clustering also defined a hypermethylated luminal-enriched tumor cluster 3; gene ontology analysis of cluster 3 hypermethy...

  14. Epigenomic Analysis of Aberrantly Methylated Genes in Colorectal Cancer OmicsDI

    ID: E-GEOD-17648

    Date Released: 06-10-2011

    Description: y studies (ADHFE1, BOLL, SLC6A15, ADAMTS5, TFPI2, EYA4, NPY, TWIST1, LAMA1, GAS7) and 2 CpG sites showing hypomethylaion (MAEL, SFT2D3) in CRC compared to normal mucosa using pyrosequencing. The methylation status measured by pyrosequencing was consistent with the methylation array data. In conclusion, we have shown that methylation profiling based on beadchip arrays is an effective method for screening for aberrantly methylated genes in CRC. In addition, we identified novel methylated genes that are candidate diagnostic or prognostic markers for CRC. We measured the methylation status of the 27,578 CpG sites (Human Methylation27 DNA Analysis BeadChip) in 22 pairs of CRC tissue and adjacent normal mucosa to identify genes that are commonly aberrantly methylated in CRC....


Displaying 14 of 14 results for "EYA4"